ERBB2 c.3046G>T ;(p.D1016Y)

Variant ID: 17-37883143-G-T

NM_004448.2(ERBB2):c.3046G>T;(p.D1016Y)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Eli, Lisa D LD; Kavuri, Shyam M SM
Publication Date: 2022

Variant appearance in text: HER2: D1016Y
PubMed Link: 36627899
Variant Present in the following documents:
  • cdr-5-4-873.pdf
View BVdb publication page



Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.

Npj Precision Oncology
Finkle, Justin D JD; Boulos, Hala H; Driessen, Terri M TM; Lo, Christine C; Blidner, Richard A RA; Hafez, Ashraf A; Khan, Aly A AA; Lozac'hmeur, Ariane A; McKinnon, Kelly E KE; Perera, Jason J; Zhu, Wei W; Dowlati, Afshin A; White, Kevin P KP; Tell, Robert R; Beaubier, Nike N
Publication Date: 2021-07-02

Variant appearance in text: ERBB2: Asp1016Tyr
PubMed Link: 34215841
Variant Present in the following documents:
  • 41698_2021_202_MOESM1_ESM.pdf
View BVdb publication page